FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Didn’t file your taxes on time? Here’s what a tax expert says you should do next

Republicans bet higher tax refunds will boost midterm chances as blue states resist relief

S&P 500 Smashed Another Record Wednesday, Signaling the Markets Believe Trump That the Iran Conflict Is Ending

Democrats vow to block next Trump Supreme Court pick amid Alito speculation

Democratic Rep. Calls to ‘Eliminate the President of the United States from the Office Right Now’

Homeland Security official’s killing leaves agency ‘devastated’ as vetting breakdown exposed

Swalwell’s mounting sexual misconduct allegations threaten career beyond politics, experts warn

Trump Admin Moves to Wipe Out the Last Remaining Convictions from January 6, Specifically Regarding Proud Boys and Oath Keepers

Virginia redistricting referendum tightens into a dead heat as early voting surges

2 detained after shooting in New York leaves 15-year-old killed, two others wounded: police

Guards at ‘Alligator Alcatraz’ beat, pepper-sprayed detainees, lawyer says

‘We’re taxing the rich’: NYC Mayor Mamdani touts new $500M-a-year tax on luxury second homes

Navy reservist accused of murdering wife and hiding her body in freezer arrested after international manhunt

Watch: Comedian Dave Chappelle Refuses to Let NPR Reporter Shame Him for Trans Jokes

Sotomayor walks back remarks criticizing Kavanaugh, says comments were ‘inappropriate’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”